You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 7, July 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (26)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Cerebrovascular Disease
 •Dementias
 •Alert me on articles by topic

Clinical and Neuropathological Characteristics of Hippocampal Sclerosis

A Community-Based Study

James B. Leverenz, MD; Christina M. Agustin, BS; Debby Tsuang, MD; Elaine R. Peskind, MD; Steven D. Edland, PhD; David Nochlin, MD; Lillian DiGiacomo, BS; James D. Bowen, MD; Wayne C. McCormick, MD; Linda Teri, PhD; Murray A. Raskind, MD; Walter A. Kukull, PhD; Eric B. Larson, MD, MPH

Arch Neurol. 2002;59:1099-1106.

Background  Hippocampal sclerosis (HS) is a neuropathologic finding characterized by neuronal loss and gliosis in the CA-1 and subiculum of the hippocampus. Previous studies of HS have shown that this is a common postmortem finding in elderly subjects with dementia. However, these studies were from selected samples and therefore are not necessarily representative of patients seen in the general medical community.

Objectives  To examine the clinical and pathologic characteristics of HS in a community-based case series of dementia and to compare these characteristics with those observed in subjects with Alzheimer disease (AD) from the same study sample.

Methods  One hundred thirty-four autopsy cases were available from a community-based registry of dementia. Sixteen cases (12%) had a postmortem diagnosis of HS. Thirty-two comparison control cases with a neuropathologic diagnosis of AD were selected from the same files. Each case of HS was reviewed for HS neuropathologic features, including severity, distribution, and additional pathologic processes. Blinded review of clinical characteristics for the HS and control groups was performed to assess risk factors.

Results  There was a wide range of severity and distribution of HS lesions between cases and substantial variability in lesion severity and age within individual cases. Serial neuropsychologic and behavioral assessments revealed similar clinical features and rates of dementia progression between HS and AD groups. Of all neuropsychologic tests performed at enrollment, only enhanced performance on Trails A differentiated the HS from the AD group (64 seconds, 0 errors vs 114 seconds, 0.6 errors; P<=.05). The number of AD cases with at least 1 apolipoprotein {epsilon}4 allele was significantly greater than the HS cases (61% vs 31%; {chi}2 = 3.81, P<=.05). Although medical record review indicated higher frequencies of clinical stroke and neuroradiologic white matter abnormalities in the HS group, risk factors for vascular disease and neuropathologic evidence of cerebrovascular disease did not differ between the groups.

Conclusions  Our results suggest that HS is a frequent pathologic finding in community-based dementia. Individuals with HS have similar initial symptoms and rates of dementia progression to those with AD and therefore are frequently misclassified as having AD. Our clinical and pathologic findings suggest that HS has characteristics of a progressive disorder although the underlying cause remains elusive.


From the Department of Veterans Affairs, Northwest Network Mental Illness Research, Education, and Clinical Center, Seattle, Wash (Drs Leverenz, Tsuang, Peskind, and Raskind); Departments of Epidemiology (Dr Kukull), Medicine (Drs McCormick and Larson), Neurology (Drs Leverenz and Bowen), Nursing (Dr Teri), Pathology, Division of Neuropathology (Dr Nochlin), and Psychiatry and Behavioral Sciences (Drs Leverenz, Tsuang, Peskind, and Raskind, and Mss Agustin and DiGiacomo), University of Washington, Seattle; and Mayo Clinic, Rochester, Minn (Dr Edland).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is amnestic mild cognitive impairment always AD?
Jagust
Neurology 2008;70:502-503.
FULL TEXT  

Frontotemporal Lobar Degeneration Without Lobar Atrophy
Josephs et al.
Arch Neurol 2006;63:1632-1638.
ABSTRACT | FULL TEXT  

Neuropathologic Features of Amnestic Mild Cognitive Impairment
Petersen et al.
Arch Neurol 2006;63:665-672.
ABSTRACT | FULL TEXT  

Hippocampal sclerosis in Alzheimer disease and other dementias
Attems and Jellinger
Neurology 2006;66:775-775.
FULL TEXT  

Quantitative post-mortem study of the hippocampus in chronic epilepsy: seizures do not inevitably cause neuronal loss
Thom et al.
Brain 2005;128:1344-1357.
ABSTRACT | FULL TEXT  

Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia
Honig et al.
Neurology 2005;64:1102-1102.
FULL TEXT  

Hippocampal sclerosis dementia: Expanding the phenotypes of frontotemporal dementias?
Lippa and Dickson
Neurology 2004;63:414-415.
FULL TEXT  

Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease
Blass et al.
Neurology 2004;63:492-497.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.